World
Academy of Anti-Aging Medicine
The
WAAAM is dedicated to the protection and preservation of the health
of the public, and the advancement of education in connection
with anti-ageing medicine. By promoting understanding and research
into anti-aging medicine, it is hoped that the speciality will
become better established in the UK and abroad. The wider use
of anti-ageing therapies should lead to general relief from the
effects of degenerative disease, as well as a reduction in the
economic burden of treating and caring for sufferers. The benefits
derived from the increased use of anti-ageing therapies and techniques
could be immense. If biological ageing can be delayed, or even
reversed, humans could live longer, healthier lives, without the
quality of their later years being impaired by the onset of degenerative
disease.
The
WAAAM was incorporated on 15 August 2001 in England/Wales. It
is not a commercial profit-making organization and is registered
with the UK Charity Commission. The Academy has been established
with the support and active involvement of the board of the American
Academy of Anti-Aging Medicine (‘A4M’). A4M was established in
Chicago in 1993 as a not-for-profit medical society. It is registered
as a charitable organization and is dedicated to the promotion
of research aimed at slowing and reversing the human ageing process.
A4M has a current membership of over 11,500 physicians and scientists
from over 65 countries and is recognized as a leading body in
the science of anti-ageing medicine.
While A4M has been particularly successful in promoting the
development of anti-ageing medicine in the USA, the speciality is
less well established worldwide. Accordingly, the WAAAM has been
founded as both a vehicle and a convenient forum for the
advancement of anti-ageing medicine in the UK and abroad. The
WAAAM will maintain close links with A4M at all times and has been
established with similar aims. The voting membership of the the
WAAAM will consist of the members of the A4M board of directors.
The chairman of the WAAAM’s Management Committee will be the
current chairman of A4M, at present Dr Robert Goldman. The
remaining members of the Management Committee, Heather Bird and Dr
Lynette Yong (who is also the secretary, and a resident doctor for
HB Health), are UK residents.
Anti-Aging Academies
Collaborate To Advance Anti-Aging Medicine World-Wide.
Dr. Robert
Goldman, WAAAM Director, and Heather Bird, WAAAM Board Member,
attend meetings and award ceremonies, as A4M and WAAAM collaborate
with the newly established Mediterranean Academy of Anti-Aging
Medicine to promote Anti-Aging Medicine world-wide and plan for
an October conference in Catania, Italy.
Meetings were held to further the goals of global expansion for
Anti-Aging Medicine and to make plans for Catania, Italy to be the
host venue to an A4M Continuing Medical Education co-venture
taking place October 8 - 12, 2004.
On. Prof, Umberto Scapagnini MD, Mayor of Catania and member of
the European Parliament, presented Dr. Robert Goldman, A4M
Chairman with the key to the city of Catania, Italy.
A4M is a founding organization of the World Anti-Aging Academy of
Anti-Aging Medicine, the goal of which is to unify global medical
data and patient treatment information, sharing these developments
in anti-aging medical therapeutics in a centralized manner, the
World Anti-Aging Academy of Anti-Aging Medicine has adopted the
Olympic model for global expansion by developing strong
international partnerships with individuals placed in prominent
positions in their respective medical commissions, governmental
bodies, and academic research-based affiliates and universities.
Background
to Anti-Ageing Medicine
 Anti-ageing
medicine became an established medical speciality in the USA
during the 1990s. Practitioners in the field recognize that the
degenerative effect of biological aging leaves the body steadily
less able to resist pathogens and combat disease. They believe
that if ageing can be slowed, the prevalence and acuteness of many
of the diseases and disabilities associated with it can be
reduced. Broadly speaking, the approach is to treat ageing as a
disease in itself. Anti-ageing research, while embracing
sophisticated high-tech innovations, aligns itself mostly with
low-cost preventative medicine. Practitioners believe that
Biologically Identical Hormone Replacement, correct use of
nutritional supplements and lifestyle changes, including stress
management and exercise, can slow the ageing process. Anti-ageing
therapies have the potential to reinforce bodily self-maintenance
and thus reduce the impact of the degenerative disease. Older
individuals can therefore remain healthy and unencumbered by
debility for a considerably longer period of time. Moreover, if
current attitudes to employment and retirement are re-examined,
anti-ageing practitioners see no reason why the elderly should not
remain as productive contributors in the work place as well as at
home. Indeed, some studies suggest that if anti-ageing therapies
are successfully employed, the average productive life of humans
could be extended beyond 100 years. |
